Leadership Team & Advisers

Dr. Tim Linnet - Founder, CEO   Tim is a Co-Founder, Member of the Board and acts as the company CEO.  He was responsible for raising $1.5M in investment capital for Linnet Bio since 2010. In 2014, he managed the acquisitions team for a $50M private equity fund.  He has continued his education through Harvard’s executive training program with classes in statistics and finances.  He leads sales, licensing, research and fundraising efforts.

Doug Morgan - Adviser, Licensing Team  Doug advises Linnet on general biotech industry matters and research activities.  Doug’s career in the pharmaceutical industry includes Sr. Dir. Translational Medicine at Regeneron, Program Executive at Biogen, Assistant Director at TAP Pharmaceuticals and positions at Abbott and Hoffmann-La Roche.  His specialties include: due diligence operations, building integrated development plans, project management, alliance management, drug discovery. He was provided advisor equity for Linnet and is the US Director for BSV.

Joachim Greuel - Adviser, Licensing Team  Joachim is the founder of Bio Science Valuation and an advisor for valuation and in/out licensing efforts for Linnet.  Joachim earned his Ph.D. in Physiology 'Summa Cum Laude' from the Max-Planck-Institute for Brain Research in Frankfurt (Germany) and his MBA from the Wharton School of the University of Pennsylvania (USA).  Joachim began his professional career as head of a research team at Bayer AG (Germany). After his business education he joined the strategic services practice of Andersen Consulting (Switzerland and Germany). Before founding Bioscience Valuation Joachim was investment manager at New Medical Technologies, a Swiss venture capital fund. BSV has completed over $1B in pharma deals.

Eli Maloley - Adviser  Linnet Investor and Co-Founder of FireFly Computers, a desktop virtualization company that has grossed over $11 million in sales in just over two years.  Founder of Maloley Ventures.

Dr. Stan Linnet - Founder, Chairman  Stan is a Co-Founder, Chairman of the Board and has spent 30+ years in retail pharmacy management.  Stan supports operations, shipping and provides financial oversight.

James Miller - Adviser Previous: (Consumer Products) VP Sales, Share Holder, Sales Director, Regional Manager, District Manager etc. for Gillette, Novartis, Nature’s Way, Medtech, and Nabisco.

Jason Hull - Adviser  Fourth generation serial entrepreneur. Founder & CEO Balanced Edge.  President for Practical Business Consulting & H2CC. Co-Founder 3HG Enterprises, Inc.  Jason currently manages his commercial real estate that range from golf courses to shopping centers.

Ted Kromer - Adviser Former Director at Roche.

Robert Lincoln "Bud" Hancock - Adviser Founder of 6 international not for profit organizations.  Pioneer in micro-loan industry spanning across several continents.  International Director and Coordinator to several US Government and other Agencies.  Liaison with U.S. Congress and adviser to President Reagan.

Dr. William Chan, Lead Research Consultant  William serves as the liaison between University of the Pacific School of Pharmacy and Linnet. He has been studying the AhR since 1993 and has received a total of four grants from the NIH since 1999.  He is the Department Chair at University of the Pacific for Post-Graduate Research.  PharmD, University of California, San Francisco, 1986.  PhD, University of California, San Francisco, 1991. PostDoc in Environmental Toxicology, University of California, Davis, 1992. PostDoc in Molecular Pharmacology, Northwestern University Medical School, 1993-1996

Susan Gibson - Board of Directors  Susan is a Linnet Investor and a member of our Board of Directors.  She advises for biotech industry general knowledge, strategy, market intelligence, fundraising and product pipeline strategies.  Susan is a diversely experienced leader with over 25 years of pharmaceutical, biotech, and/or medical device experience spanning all commercial and many clinical areas.  She received her BS in Pharmacy from Purdue and her MBA from Harvard.  She was an Investor with Sand Hill Angels and worked at Syntex, Elan Pharmaceuticals, Genentech, Corgentech, J&J (Scios division) and was Vice President of Marketing at EndoGastric Solutions.  She currently serves as the Head of Market Intelligence at Jazz Pharmaceuticals ($1.5B pharmaceutical co.).

Deanna Gallagher - Board of Directors Deanna is Linnet Investor and member of our Board of Directors.   She advises on strategy and long-term planning.  Deanna founded and successfully sold her SAAS technology business and now spends her time on a non-profit Shasta Thrive.

Dave Jensen - Prev. Board of Directors (Retired) Owner of Redding Distribution Company (Retired).

Nicolas Acuña - Adviser CoFounder Ebbex and BOXtastic- Nicolas has over 10 years experience in entrepreneurship and consulting.  He has built mobile applications for Google, Amazon, Exon Mobile PBS and many others. He is also a political consultant to presidential and state government campaigns in South America.

Dr. Don Brown - Consultant, Adviser Don is one of the leading authorities in the USA on the safety and efficacy of dietary supplements, evidence-based herbal medicine, and probiotics.  director of Natural Product Research Consultants (NPRC). Advisory Board of the American Botanical Council (ABC). Previous Adviser to the NIH.


Other (Law):

Corporation and Stock - Tom Armstrong JD, Redwood City

Contract - Richard S, Price II, Attorney Fullerton, CA

Intellectual Property - Brian Boyer PhD, Redwood City

FDA - Richard Abood, PharmD, JD

 

Other (Research):

Pharmacokinetics - Miki Park, PhD University of the Pacific Thomas J. Long School of Pharmacy

Peter R. Martin, M.D., - Professor of Psychiatry and Pharmacology, Director, Division of Addiction Psychiatry and Vanderbilt Addiction Center, Vanderbilt Psychiatric Hospital